Clinical Trials
3 trialsNCT02574728 2026-03-02
AflacST1502
Emory University
Phase 2 Active not recruiting
NCT05634785 2026-01-09
CD30 CAR for CD30+ NSGCT
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT02161692 2014-06-12
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed